ReposiTrak (NYSE:TRAK) Shares Down 0.2% – Here’s Why
Key Points
- ReposiTrak Inc. shares fell 0.2% to $16.12 during mid-day trading, with a significant decline in trading volume by 27% compared to its average session volume.
- Wall Street Zen upgraded ReposiTrak’s rating from “hold” to “buy,” indicating positive sentiment among analysts about the company’s future performance.
- Insider activity included CEO Randall K. Fields selling 3,500 shares for about $58,940, resulting in a 3.10% decrease in his ownership stake.
- Looking to export and analyze ReposiTrak data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.
ReposiTrak Inc. (NYSE:TRAK – Get Free Report)’s share price fell 0.2% during mid-day trading on Thursday . The company traded as low as $15.88 and last traded at $16.12. 39,139 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 53,906 shares. The stock had previously closed at $16.16.
Get ReposiTrak alerts:
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised shares of ReposiTrak from a “hold” rating to a “buy” rating in a research note on Thursday, May 22nd.
View Our Latest Analysis on ReposiTrak
ReposiTrak Stock Performance
The business has a 50 day moving average of $18.34. The firm has a market capitalization of $294.61 million, a PE ratio of 47.41 and a beta of 0.50. The company has a quick ratio of 6.03, a current ratio of 6.03 and a debt-to-equity ratio of 0.01.
ReposiTrak Cuts Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 14th. Shareholders of record on Monday, June 30th were given a $0.0182 dividend. The ex-dividend date of this dividend was Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.5%. ReposiTrak’s dividend payout ratio is currently 23.53%.
Insider Activity at ReposiTrak
In other ReposiTrak news, CEO Randall K. Fields sold 3,500 shares of the stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $16.84, for a total value of $58,940.00. Following the sale, the chief executive officer directly owned 109,500 shares of the company’s stock, valued at approximately $1,843,980. This represents a 3.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders have sold 89,000 shares of company stock valued at $1,721,701. Corporate insiders own 44.00% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its holdings in shares of ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after buying an additional 634 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in ReposiTrak by 397.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after purchasing an additional 2,892 shares during the period. R Squared Ltd acquired a new stake in ReposiTrak during the 2nd quarter worth $235,000. Rhumbline Advisers raised its position in ReposiTrak by 69.1% during the 2nd quarter. Rhumbline Advisers now owns 18,036 shares of the company’s stock worth $354,000 after buying an additional 7,371 shares during the last quarter. Finally, Coldstream Capital Management Inc. raised its position in ReposiTrak by 47,619.0% during the 2nd quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company’s stock worth $394,000 after buying an additional 20,000 shares during the last quarter. Institutional investors and hedge funds own 27.35% of the company’s stock.
About ReposiTrak
(Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in ReposiTrak Right Now?
Before you consider ReposiTrak, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and ReposiTrak wasn’t on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
7 Stocks to Buy And Hold Forever
Enter your email address and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising.
